Clinical Trial Update: Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dapagliflozin added to metformin and a sulfonylurea in adults with type 2 diabetes and inadequate glycemic control; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, High HbA1c Level | Phase 3 | Status: COMPLETED | Results posted: 2013-12-27